4Caponigro F.Rationale and clinical validation of epidermal growth factor receptor as a target in the treatment of head and neck cancer. Anti Cancer Drugs . 2004
5Soulieres D,SenzerNN,Vokes EE,et al.Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patientswith recurrent ormetastatic squamous cell cancer of the head and neck. Journal of Clinical Oncology . 2004
二级参考文献30
1Benninger MS.Microdissection or microspot CO2laser for limited vocal fold benign lesions: a prospective randomized trial.Laryngoscope.2000; 110( Suppl): 1-17.
2Peretti G, Piazza C, Balzanelli C,et al.Vocal outcome after endo scopic cordectomies for Tis and T1 glottic carcinomas.Ann Otol Rhinol Laryngol.2003;112: 174-179.
3Vikram B, Strong EW, Shah JP, et al.Failure at the primary site following multimodality treatment in advanced head and neck cancer.Head Neck Surg.1984; 6: 720-723.
4Looser KG, Shah IP, Strong EW.The significance of "positive" margins in surgically resected epidermoid carcinoma.Head Neck Surg.1978; 1: 107-111.
5Remacle M, Lawson G.Transoral laser microsurgery is the recommended treatment for early glottic cancers.Acta Otorhinolaryngol Belg.1999; 53: 175-178.
6Byers RM, Wolf PF, Ballantyne AJ.Rationale for elective modified neck dissection.Head Neck Surg.1988; 10: 160-167.
7Hirayama M, Takahashi H, Yao K, et al.Clinical study of T1a glottic-type cancer.Acta Otolaryngol.2002;(Suppl 547):67-71.
8Shvero J, Koren R, Zohar L, et al.Laser surgery for the treatment of glottic carcinomas.Am J Otolaryngol.2003;24: 28-33.
9Yumi Knegae, Miho Makimura and Izumu Satio. A simple and efficient method for purifica-tion of infections recombinant adenovirus. Jpn J Med Sci Biol, 1994,47:157-166.
10Brand K, Klocke R, Pobetaling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999, 6: 1054-1063.
4Wang X M, Wang X F, Li J, et al. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines [ J ]. Ann Surg, 1998, 227(6) : 922 -931.
5Kim D H, Kim M, Kwon H J. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents [ J]. J Biochem Mol Biol, 2003, 36(1): 110-119.
6Takai N, Desmond J C, Kumagai T, et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells[ J]. Clin Cancer Res, 2004, 10(3) : 1141 -1149.
7Wong S C, Chan J K, Lee K C, et al. Differential expression of p16/ p21/p27 and cyclin D1/D3 and their relationships to cell proliferation, apoptosis and tumour progression in invasive ductal carcinoma of the breast[J]. J Pathol, 2001, 194(1) : 35 -42.
8Shin S, Sung B J, Cho Y S, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 [ J ]. Biochemistry, 2001, 40(4): 1117-1123.
